123 related articles for article (PubMed ID: 3621221)
41. [Intraepithelial carcinoma and invasive carcinoma of the vulva, vagina and penis in Ile-de-france. Enquete PETRI on 423 cases].
Aynaud O; Asselain B; Bergeron C; Cartier I; Martin E; Sastre-Garau X; Souques M; Zummer K
Ann Dermatol Venereol; 2000 May; 127(5):479-83. PubMed ID: 10863176
[TBL] [Abstract][Full Text] [Related]
42. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.
Fonseca-Moutinho JA; Coelho MC; Silva DP
J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688
[TBL] [Abstract][Full Text] [Related]
43. Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation.
Landrum LM; Skaggs V; Gould N; Walker JL; McMeekin DS
Gynecol Oncol; 2008 Mar; 108(3):584-90. PubMed ID: 18155755
[TBL] [Abstract][Full Text] [Related]
44. Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
Forastiere AA; Crain SM; Garbino C; Tipping SJ; Perry DJ; Kasdorf H; Van Echo DA
Cancer Treat Rep; 1984 Apr; 68(4):687-8. PubMed ID: 6713424
[No Abstract] [Full Text] [Related]
45. Radiotherapy alone and chemoirradiation in recurrent squamous cell carcinoma of the vulva.
Raffetto N; Tombolini V; Santarelli M; Valeriani M; Galla DA; Enrici RM
Anticancer Res; 2003; 23(3C):3105-8. PubMed ID: 12926170
[TBL] [Abstract][Full Text] [Related]
46. Squamous cell carcinoma of the vulva stage IA: long-term results.
Magrina JF; Gonzalez-Bosquet J; Weaver AL; Gaffey TA; Leslie KO; Webb MJ; Podratz KC
Gynecol Oncol; 2000 Jan; 76(1):24-7. PubMed ID: 10620436
[TBL] [Abstract][Full Text] [Related]
47. Prognostic factors for recurrence and survival in primary vulvar squamous cell cancer.
Ayhan A; Velipasaoglu M; Salman MC; Guven S; Gultekin M; Bayraktar O
Acta Obstet Gynecol Scand; 2008; 87(11):1143-9. PubMed ID: 18949585
[TBL] [Abstract][Full Text] [Related]
48. Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva.
Cunningham MJ; Goyer RP; Gibbons SK; Kredentser DC; Malfetano JH; Keys H
Gynecol Oncol; 1997 Aug; 66(2):258-61. PubMed ID: 9264573
[TBL] [Abstract][Full Text] [Related]
49. [Treatment of advanced and recurrent gynecologic cancer with chemotherapy by cannula perfusion into both internal iliac arteries].
Zhao LR; Zhao WX; Shao MH
Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):607-9, 638. PubMed ID: 7536145
[TBL] [Abstract][Full Text] [Related]
50. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
51. Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.
Weiselberg L; Budman DR; Schulman P; Vinciguerra V; Degnan TJ; Pasmantier M
Cancer Treat Rep; 1982 Aug; 66(8):1675-6. PubMed ID: 7201885
[No Abstract] [Full Text] [Related]
52. Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Morris M; Blessing JA; Monk BJ; McGehee R; Moore DH
J Clin Oncol; 2004 Aug; 22(16):3340-4. PubMed ID: 15310778
[TBL] [Abstract][Full Text] [Related]
53. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix.
Morris M; Brader KR; Burke TW; Levenback CF; Gershenson DM
Gynecol Oncol; 1998 Aug; 70(2):215-8. PubMed ID: 9740693
[TBL] [Abstract][Full Text] [Related]
54. Histologic prognosticators in stage I squamous cell carcinoma of the vulva.
Ross MJ; Ehrmann RL
Obstet Gynecol; 1987 Nov; 70(5):774-84. PubMed ID: 3658290
[TBL] [Abstract][Full Text] [Related]
55. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva.
Eifel PJ; Morris M; Burke TW; Levenback C; Gershenson DM
Gynecol Oncol; 1995 Oct; 59(1):51-6. PubMed ID: 7557615
[TBL] [Abstract][Full Text] [Related]
56. Vulvar carcinoma. The price of less radical surgery.
De Hullu JA; Hollema H; Lolkema S; Boezen M; Boonstra H; Burger MP; Aalders JG; Mourits MJ; Van Der Zee AG
Cancer; 2002 Dec; 95(11):2331-8. PubMed ID: 12436439
[TBL] [Abstract][Full Text] [Related]
57. A case of recurrent squamous cell carcinoma of the vulva successfully treated by combination therapy with cetuximab and paclitaxel.
Matsuzawa M; Inozume T; Sano S; Ando N; Onuma T; Harada K; Kawamura T; Shimada S
Br J Dermatol; 2016 Mar; 174(3):677-8. PubMed ID: 26399700
[No Abstract] [Full Text] [Related]
58. Intermittent intravenous methotrexate in the treatment of advanced epidermoid carcinoma of the cervix and vulvovagina.
Haffner WH; Frick HC
Cancer; 1970 Oct; 26(4):812-5. PubMed ID: 5506605
[No Abstract] [Full Text] [Related]
59. [Autoradiographic and histological findings in vulvar carcinoma during local bleomycin therapy].
Kaltenbach FJ; Keil G
Strahlentherapie Sonderb; 1978; 75():185-90. PubMed ID: 95494
[No Abstract] [Full Text] [Related]
60. Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial.
How JA; Jazaeri AA; Soliman PT; Fleming ND; Gong J; Piha-Paul SA; Janku F; Stephen B; Naing A
Sci Rep; 2021 Feb; 11(1):3667. PubMed ID: 33574401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
